NIH-funded research R01 grant

Photobiomodulation therapy for chronic head and neck lymphedema in cancer survivors

Official title: Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors with Chronic Lymphedema

Funded at University of Pennsylvania · NIH-11324201 · Data updated 2026-11-12

A 5-year, multi-site trial tests a light-based therapy to reduce long-term neck and jaw swelling in people who survived head and neck cancer.

More Head and Neck Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startApril 23, 2025
Project endMarch 31, 2030
Funding year2026
Award (this year)$693,942
NIH project number5R01CA289307-02
Project IDNIH-11324201 on NIH RePORTER

Who could benefit from this research

Could help

Adults with chronic head and neck lymphedema following cancer treatment, who have completed standard decongestive therapy and meet trial criteria.

Less likely to help

Some participants may not experience noticeable changes in swelling or function and may not benefit from the therapy.

What this research studies

If you are a head and neck cancer survivor with chronic swelling in the head/neck area, this study wants to see if a non-drug light therapy can help reduce your lymphedema and improve comfort and movement. The trial design is placebo-controlled and blinded to minimize bias, with sessions conducted at multiple sites. Researchers will closely monitor safety and measure changes in swelling, jaw motion, swallowing, and quality of life. The goal is to find a safe, effective option for managing chronic lymphedema when standard care isn’t enough.

Why it matters

Potential benefit: If successful, participants may experience reduced swelling and improved function, impacting daily activities and comfort.

How similar studies have gone: Preliminary pilot data showed feasibility and potential efficacy, supporting a larger, rigorous trial.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Deng, Jie — University of Pennsylvania
  • Study coordinator: Deng, Jie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.